MSc by Research Drug Design and Delivery in Carlilse United Kingdom | University of Lancashire

The Drug Design and Delivery research group focuses on creating and evaluating novel pharmaceuticals while advancing formulation techniques and analytical methods for targeted therapy delivery. Our work addresses inflammatory disorders, cancer, infectious diseases, respiratory conditions, metabolic disorders, and neurological ailments. Beyond developing proprietary compounds, we actively engage in collaborative projects and contract research to drive translational outcomes.

Our team comprises globally recognized experts who partner with major pharmaceutical firms and emerging biotech companies, yielding multiple patented innovations. We secure UK funding to collaborate with industry specialists possessing synthesis and development expertise.

Our drug discovery efforts encompass both chemical synthesis and biological assessment of potential anticancer and antimicrobial agents, including prodrug development. We pioneer novel synthetic approaches for creating therapeutic compounds, prodrug systems, and advanced nanomaterials.

Formulation expertise centers on nanotechnology solutions, overcoming biopharmaceutical barriers, solubility enhancement strategies, and clinical pharmaceutical studies examining drug interactions. Additionally, we specialize in pulmonary drug delivery systems.